Chonluten – Peptide Complex for Respiratory Support | Khavinson Bioregulators & Peptides

Description

Chonluten is a scientifically developed peptide complex designed to support lung function and promote respiratory health. This bioregulator may help maintain optimal lung performance, especially in individuals experiencing respiratory challenges due to chronic or acute conditions.

The primary active ingredients include essential amino acids such as glycine, glutamic acid, and aspartic acid, which may work to support normal cellular function in the lungs and bronchial mucosa. This peptide complex may be beneficial in managing respiratory disorders, supporting recovery from lung injuries, and promoting respiratory health across various age groups.

Key Benefits (Supportive Claims):

• May support respiratory function in acute and chronic conditions

• May help reduce coughing, improve breathing, and reduce sputum production

• Supports recovery from lung injuries, respiratory distress, and aftereffects of artificial ventilation

• May enhance aerobic capacity, respiratory reserve, and physical performance

• Supports respiratory health maintenance in elderly individuals

Clinical Context (Informational):

Studies suggest that Chonluten may contribute to reducing inflammation and supporting lung tissue regeneration. It is used in contexts including chronic respiratory failure, cardiopulmonary failure, tuberculosis remission, and recovery from pneumonia and toxic lung damage.

Directions for Use:

Adults should take 1-2 capsules 1-2 times daily with meals. Recommended usage duration is 10-30 days, with the possibility to repeat after 4-6 months as needed.

Composition per Capsule:

• Peptide complex AC-7 (glycine, glutamic acid, aspartic acid)

• MCC carrier

• Capsule shell: hydroxypropyl methylcellulose, purified water, carrageenan, potassium acetate

• Anti-caking agent: calcium stearate

Conditions Benefited (Informational):

• Chronic respiratory failure

• Chronic cardiopulmonary failure

• Post-pneumonia recovery

• After-effects of prolonged artificial ventilation

• Respiratory distress syndrome

• Pulmonary tuberculosis (remission)

• Chest injuries and burns to the upper respiratory tract

• Toxic lung damage (e.g., carbon monoxide poisoning)

• Enhanced performance during intense exercise

• Respiratory maintenance in elderly individuals

Important Notice:

Not for human use. For research purposes only.